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https://doi.org/10.1016/j.celrep.2020.107933SUMMARYThere is increasing evidence that the architecture of long non-coding RNAs (lncRNAs)—just like that of pro-
teins—is hierarchically organized into independently folding sub-modules with distinct functions. Studies
characterizing the cellular activities of such modules, however, are rare. The lncRNA growth arrest specific
5 (GAS5) is a key regulator of cell survival in response to stress and nutrient availability. We use SHAPE-
MaP to probe the structure of GAS5 and identify three separate structural modules that act independently
in leukemic T cells. The 50 terminal module with low secondary structure content affects basal survival and
slows the cell cycle, whereas the highly structured core module mediates the effects of mammalian target
of rapamycin (mTOR) inhibition on cell growth. These results highlight the central role of GAS5 in regulating
cell survival and reveal how a single lncRNA transcript utilizes a modular structure-function relationship to
respond to a variety of cellular stresses under various cellular conditions.INTRODUCTION
Long non-coding RNAs (lncRNAs) represent a broad class of
transcripts with critical roles in all aspects of cellular biology
and a wide spectrum of molecular functions (Kopp and Mendell,
2018). They are aberrantly expressed in various cancers, are key
players in tumor development and progression, and are linked to
resistance against chemotherapy, demonstrating their potential
as biomarkers and therapeutic targets (Arun et al., 2018). Deter-
mining the specific molecular function of individual lncRNAs,
however, has proven difficult, and the mechanisms of most
lncRNAs remain uncharacterized.
Structural studies of lncRNAs can provide valuable insight into
their functional properties. Focused, in-depth secondary struc-
ture analyses of individual lncRNAs, for example, have identified
modular architectures with distinct sub-domains (Hawkes et al.,
2016; Ilik et al., 2013; Novikova et al., 2012; Smola et al., 2016;
Somarowthu et al., 2015). Few studies, however, have tested if
these sub-domains function independently in cells (Quinn
et al., 2014; Uroda et al., 2019; Chillo´n and Pyle, 2016).
The growth arrest-specific 5 (GAS5) gene encodes a lncRNA
that was identified in a subtraction cDNA library enriched for
RNA sequences preferentially expressed in growth-arrested
cells (Schneider et al., 1988). Later studies showed that it is
required for normal growth arrest, slows down the cell cycle
(Mourtada-Maarabouni et al., 2008), and controls apoptosis
(Kino et al., 2010; Mourtada-Maarabouni et al., 2010; PickardThis is an open access article under the CC BY-Net al., 2013). In agreement with this role in inhibiting cell prolifer-
ation, GAS5 expression is reduced in numerous cancers,
including breast, lung, gastric, pancreatic, bladder, and prostate
cancer, as well as renal cell carcinoma, B cell lymphoma, and
leukemia (Yu and Li, 2015).
The GAS5 gene contains a number of intronic small nucleolar
RNAs (snoRNAs) involved in ribosome biogenesis (Smith and
Steitz, 1998). It is therefore highly transcribed in all tissue types
and is one of the most highly expressed lncRNAs in the genome
(Gibb et al., 2011). Like many other lncRNAs, the GAS5 RNA is
spliced and polyadenylated, and it associates with ribosomes
(Coccia et al., 1992; Renganathan et al., 2014). In actively
dividing cells, GAS5 levels are kept low by non-sense mediated
decay (NMD) (Mourtada-Maarabouni and Williams, 2013; Smith
and Steitz, 1998), a process requiring active translation (Isken
and Maquat, 2007). Upon exposure to stress such as density ar-
rest or nutrient deprivation, translation is inhibited, and GAS5
levels increase (Coccia et al., 1992; Fleming et al., 1998). Under
these conditions, GAS5 exerts its negative effects on cell prolif-
eration and survival.
Themammalian target of rapamycin (mTOR) pathway is a cen-
tral hub for regulating cell growth in response to intra- and extra-
cellular signals, such as growth factors and mitogens or the
availability of nutrients and ATP. Inhibition of mTOR by rapamy-
cin results in inhibition of cell proliferation, and GAS5 is required
for this effect in human immune cells (Mourtada-Maarabouni
et al., 2010). These observations establish GAS5 as a centralCell Reports 32, 107933, July 21, 2020 ª 2020 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ing cell growth. However, mechanistic insight into the function
the GAS5 lncRNA is limited.
At its 30 terminal end (nucleotides 546–566), GAS5 contains a
predicted stem-loop structure that specifically interacts with ste-
roid receptors (SRs) and blocks DNA-dependent steroid
signaling (Hudson et al., 2014; Kino et al., 2010). In steroid-sen-
sitive cancer cells, such as prostate cancers, this SR binding
motif is responsible for GAS5 effects on cell growth (Hudson
et al., 2014). This is not true in other cell types, however, where
proliferation is not strongly dependent on SR signaling. There-
fore, other regions in GAS5 must be active and use different
mechanisms to regulate cell survival.
Here, we use Selective 20 Hydroxyl Acylation analyzed by
Primer Extension by Mutational Probing (SHAPE-MaP) chemical
probing to analyze the secondary structure of GAS5 in vitro and
in cellulo. We find that the secondary structure of endogenous
GAS5 resembles that of in vitro transcribed GAS5 RNA. The
molecule contains three separate structural modules: a 50 mod-
ule with low secondary structure content; a highly structured
core module; and the SR binding module, which forms separate
from the rest of the molecule close to its 30 end. Functional
studies in leukemic T cells show that the 50 module mediates
GAS5’s role in inhibiting basal cell survival and slowing the cell
cycle, whereas the core module is required for mediating the ef-
fects of mTOR inhibition. These results confirm that the GAS5
structural modules function independently in cells, and each
module acts under different cellular conditions, likely using
different molecular mechanisms.
RESULTS
In Vitro SHAPE-MaP Identifies Three Structural Modules
within GAS5
We used SHAPE-MaP with 1-methyl-7-nitroisatoic anhydride
(1M7) to probe the secondary structure of in vitro transcribed
GAS5 lncRNA (ENST00000450589.5). Modified RNA was reverse
transcribed and amplified for sequencing by two overlapping
PCRs of 400 nucleotides in length each (Figure S1). We obtained
sequencing read depths of100,000–200,000 per nucleotide and
mutation rates of modified samples of0.1% (Figure S1). The re-
sultingmutation profiles allowed us to determine accurate SHAPE
reactivities for GAS5 nucleotides 1–599 (Figure 1A; SHAPE reac-
tivities and pairing probabilities). SHAPE reactivities in the overlap
between the two PCR products determined in separate analyses
showed good agreement (Spearman R = 0.79; Figure S1). Inde-
pendent experiments performed either on the same day
(Spearman R = 0.88) or several months apart also showed good
agreement (Spearman R = 0.81; Figure S1).
The SHAPE reactivity profile of GAS5 shows the typical
pattern of defined regions of low and high reactivities corre-
sponding to low and high nucleotide flexibility (Figure 1B). The
resulting GAS5 structure model identified amodular architecture
with three separate sub-modules (Figures 1B and 1C). Interest-
ingly, the short hairpin containing the SR binding motif is formed
as predicted previously (Hudson et al., 2014; Kino et al., 2010)
and is located at the 30 terminus as an independent structural
module that is separated from the rest of the molecule. This is2 Cell Reports 32, 107933, July 21, 2020consistent with the evolutionary origin of this element. It arose
in the haplorhine lineage from an Alu insertion at the GAS5
intron11/exon12 boundary (Hudson et al., 2014). Hence, it is
not present in, for example, mice, and it appears to have been
added as an independent structural and functional module late
in evolution. This observation is reminiscent of themodular archi-
tecture and function of proteins, in which domains are combined
in a mix-and-match fashion to create large, multi-domain pro-
teins with diverse functions. In analogy, the addition of the SR
binding motif expanded the functional repertoire of GAS5.
A second structural module at the 50 terminus of GAS5 is char-
acterized by high SHAPE reactivities reflecting low secondary
structure content with mostly short stretches of base-paired re-
gions (nucleotides 1–170; 78 out of 170 nucleotides predicted to
be base paired, 46%). This module coincides with GAS5’s puta-
tive open reading frame (nucleotides 31–183; Smith and Steitz,
1998), and the low structural content is consistent with efficient
translation initiation as well as elongation and might explain the
rapid and efficient degradation of the message by NMD. Low
secondary structure content also facilitates binding to miR-21
and miR-135, the binding sites of which are located within this
module (Hu et al., 2016; Song et al., 2014; Xue et al., 2016; Zhang
et al., 2013). Finally, the single-stranded RNA stretches in this re-
gion are also ideal for interaction with other complementary nu-
cleic acids such as genomic DNA or nascent RNAs. These are
common targets for lncRNA regulation via the recruitment of pro-
tein factors such as chromatin regulatory proteins.
The central region, downstream of the open reading frame and
upstream of the SR binding motif, constitutes the third structural
module of GAS5. It has a relatively high secondary structure con-
tent (nucleotides 172–540; 250 out of 369 nucleotides predicted
to be base paired, 68%). This structured core contains 12 helices
(core helices cH1–cH12), 9 stem loops, 2 three-way junctions,
and a multi-way junction connecting helices cH4 to cH11 (Fig-
ure 1C). The high secondary structure content suggests this
module forms a compact core and may act as a scaffold to re-
cruit protein interaction partners via distinct binding surfaces.
For some nucleotides in some of the core module helices (in
particular, cH2, cH7, and cH10), wemeasured high SHAPE reac-
tivities (Figures 1B and 1C). SHAPE experiments do not distin-
guish well between structural flexibility and the presence of
multiple conformations in an RNA. Highly SHAPE-modified nu-
cleotides within stems may suggest that these regions in GAS5
can adopt multiple stable conformations.
In Cellulo Structure Probing Is Similar to In Vitro Data
To assess the structure of GAS5 in its cellular environment, we
probed endogenous GAS5 in HeLa cells (Figure 2). The resulting
SHAPE profile of endogenous GAS5 shows a similar distribution
of SHAPE reactivities as samples prepared in vitro (Figure 2A).
The degree of correlation between in cellulo and in vitro data
was high and similar to that for in-cellulo-measured SHAPE reac-
tivities in the overlap of the two GAS5 amplicons used for high-
throughput sequencing (Figure 2B). To assess potential local
differences, we calculated windowed correlation coefficients
over the entire sequence (Figure 2C). The results show that in
cellulo data more strongly correlate with in vitro data than with
a random distribution.
Figure 1. SHAPE-MaP of GAS5 RNA In Vitro Identifies a Modular Architecture
(A) Exon structure of GAS5 with the putative ORF and the SR binding motif highlighted.
(B) Nucleotide resolution SHAPE reactivities for in vitro transcribed and folded GAS5 are shown color coded for low, medium, and high reactivities. Below: base-
pairing probabilities in GAS5. Arcs represent base pairs and are color coded by probability.
(C) Minimum free energy secondary structure model of GAS5 color coded for SHAPE reactivities. Structural modules are highlighted.
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similar to the endogenous lncRNA, local correlation between the
two is weaker than between two independent in vitro datasets, in
particular in the first 450 nucleotides (Figure 2C).
The observed minor differences between endogenous and
in vitro transcribed RNA may result from effects of heat denatur-
ation and refolding on the in vitro sample leading to more
compact structures (Dethoff and Weeks, 2019). Another source
of difference is found in the cellular environment of endogenousGAS5. Interactions of GAS5 with proteins or other nucleic acids
may affect SHAPE reactivities. To investigate these differences
further, we applied the deltaSHAPE algorithm (Smola et al.,
2015a) for the identification of protein binding sites from in cellulo
SHAPE-MaP data (Figure S2). Comparison of in cellulo data with
three independent in vitro datasets revealed localized sites of dif-
ferences. The 50 module contains regions with reduced SHAPE
reactivities, which is usually associated with protein binding sites
(Smola et al., 2016) and may also reflect the translation of theCell Reports 32, 107933, July 21, 2020 3
Figure 2. GAS5 SHAPE Reactivities Appear Similar In Cellulo and In Vitro
(A) SHAPE reactivities from probing endogenous GAS5 in HeLa cells.
(B) Correlation of SHAPE reactivities for individual nucleotides between different datasets. A similar degree of correlation is observedwithin the in cellulo data and
between in cellulo and in vitro datasets. Left: the two amplicons used to generate double-stranded DNA (dsDNA) for sequencing had an overlap of 132 nu-
cleotides (248–379). Shown here is the correlation between the SHAPE reactivities of those nucleotides when the two amplicons are processed separately. Right:
correlation between the in cellulo data and three independent in vitro datasets.
(C) Windowed correlation between different SHAPE-MaP datasets (over a 40-nucleotide window). IV replicates, two replicates of in vitro data; IC versus IV, in vitro
versus in cellulo data; random, in cellulo data versus randomly generated data with a similar distribution of values. Right: distribution of windowed correlation
coefficients.
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comprises sites with enhanced cellular SHAPE reactivities, sug-
gesting that minor structural changes in the structured core
occur in endogenous GAS5 (Smola et al., 2016).
It is important to note, however, that the SHAPE differences
observed here are smaller than those previously reported for
very stable ribonucleoproteins (RNPs) (Smola et al., 2015a).
The original analysis was developed using benchmark RNAs
that are short (<300 nucleotides) and form highly stable ribonu-
cleoprotein complexes (e.g., 5S rRNA and U1 small nuclear
RNA [snRNA]). Smaller differences in the case of GAS5 may
result from several factors, such as incomplete saturation of
GAS5 with cellular protein binding partners under the conditions
tested, transient protein binding, or differences between the
cytoplasmic and nuclear populations of GAS5 (probed together
in our experiments). All these factors will dilute any differences in
SHAPE reactivities and may explain the observed data.
Apoptosis and Cell Cycle Arrest Are Mediated by the 50
Module
The SR binding motif mediates most of the effects of GAS5 on
the basal survival of steroid-driven cancer cells (Hudson et al.,4 Cell Reports 32, 107933, July 21, 20202014). A single mutation in this motif that abrogates SR binding
almost completely abolished its effects on cell survival (Hudson
et al., 2014), consistent with this motif being an independent
functional module. In immune cells, which are less dependent
on SR signaling for growth (Mourtada-Maarabouni et al., 2008),
the SR binding motif mutant only partially reduces the effects
of GAS5. This suggests that other regions of the lncRNA play
important roles in regulating cell survival in those cells.
To test if the 50 terminal and core modules identified by SHAPE
are functioning independently in cells, we overexpressed these
RNAs in Jurkat and CEM-C7 leukemic T cells (Figures 3A and
3B). Overexpression of GAS5 induces robust negative effects
on cell survival (Figure 3C). These effects are mediated by an in-
crease in apoptosis and a slowing of the cell cycle, with an
increased proportion of cells in G0/G1 and a corresponding
decrease of cells in G2/M (Figures 3D–3F). Of the two GAS5
structural modules, overexpression of the core region did not
cause any significant effect on cell viability, apoptosis, or cell cy-
cle. In contrast, the 50 terminal module significantly reduced cell
viability, increased apoptosis, and completely phenocopied the
effects on the cell cycle (Figures 3C–3F). The additional negative
effects of full-length GAS5 on viable cell number and apoptosis
Figure 3. The GAS5 50 and Core Modules Act Independently under Different Cellular Conditions
In (A)–(F), cells were transfected with GAS5 constructs, or empty pcDNA3 vector as control. After 24 h, cells were replated at a fixed density for analysis after a
further 48 h. *p < 0.01 compared with cells transfected with vector alone (one-way ANOVA and Dunnet’s post hoc analysis).
(A and B) Cellular GAS5 levels for Jurkat (A) and CEM-C7 cells (B) were determined by qRT-PCR at 24 h post-transfection using two different Taqman assays to
distinguish the two modules: Exon 1 for the 50 module and exon boundary 10/11 for the core module.
(C) Cell viability was determined by flow cytometry.
(D) Basal apoptosis level was measured by acridine orange staining.
(E and F) Cell cycle analysis was assessed by flow cytometry following nuclear propidium iodide staining.
(G) Jurkat cells were transfected with one of the GAS5modules or empty vector. Cells were treated with mTOR inhibitors 24 h post-transfection. Cell growth was
measured using MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) after 72 h. Results are represented as the
percentage of inhibition of cell proliferation relative to vehicle-treated cells. *p < 0.01 compared with cells transfected with vector alone (one-way ANOVA and
Dunnet’s post hoc analysis).
(H) Jurkat cells were transfected with specific GAS5 siRNAs (SI03652537 targeting exon 3 = siRNA #1; SI03652544 targeting exon 7 = siRNA #2) or negative
control siRNA (()siRNA) and cultured at 37C. After 48 h, cells were transfected with one of the GAS5 modules or empty vector and treated with rapamycin
(2.5 mM) 24 h post-transfection. Cell growth was measured using MTS after 48 h. Results are represented as the percentage of inhibition of cell proliferation
relative to vehicle-treated cells. *p < 0.01 compared with cells transfected with ()siRNA; ªp < 0.01 compared with cells transfected with pcDNA3.1 (one-way
ANOVA and Dunnet’s post hoc analysis).
(I) qRT-PCRs for quantifying endogenous GAS5 levels. *p < 0.01 compared with cells transfected with ()siRNA (one-way ANOVA and Dunnet’s post hoc
analysis). It is of note here that siRNAs #1 and #2 were designed to target GAS5 in the 50 and core modules, respectively, so that overexpression of the modules
could be selectively controlled. qRT-PCR results, however, showed that each siRNA targeting GAS5 reduced the extent of overexpression of both modules more
so than did the control siRNA (Figure S3). This does not affect interpretation of the results since increased levels of the core module led to an increase in growth
inhibition in all cases. Data represent mean ± SEM from four independent experiments.
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et al., 2014).
mTOR Signaling Is Mediated through the GAS5
Structured Core Domain
mTOR inhibition in leukemic T cells slows cell growth, and a sub-
stantial proportion of this effect is mediated through GAS5(Mourtada-Maarabouni et al., 2010). To test if the individual mod-
ules could explain the role of GAS5 in the mTOR pathway, we
measured their effects in the presence of a series of mTOR inhib-
itors in Jurkat cells (Figures 3G and 3H). Jurkat cells were trans-
fected with the GAS5 modules, and 24 h post-transfection, cells
were treated with mTOR inhibitors. Cell growth was monitored
another 72 h later. Cells expressing the 50 module did notCell Reports 32, 107933, July 21, 2020 5
Figure 4. Distinct Secondary Structures within the GAS5 Modules Are Required for Function in Cells
(A) Design of mutations to disrupt helices 50H2 and 50H3 within the 50 module.
(B) Effects of mutations in distinct secondary structures on the activity of the 50 module in Jurkat and CEM-C7 cells.
(C) Design of mutations to disrupt helices cH4, cH6, cH11, and cH12 within the core module.
(D) Effects of mutations in distinct secondary structures on the activity of the core module in Jurkat cells in the presence of mTOR inhibitors. Data represent mean
± SEM from three independent experiments. *p < 0.01 compared with cells transfected with pcDNA3.1 (one-way ANOVA and Dunnet’s post hoc analysis).
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bition, compared to cells transfected with the empty vector (Fig-
ure 3G). The core module, however, significantly enhanced the
effect of mTOR inhibition on cell growth with all mTOR inhibitors
tested (Figure 3G).
To further support these observations, we knocked down
endogenous GAS5 using small interfering RNAs (siRNAs) and
re-introduced the GAS5 modules. Cell growth was then moni-
tored after exposure to rapamycin. siRNAs efficiently knocked
down endogenous GAS5 (Figure 3I). Subsequent overexpres-
sion of the 50 module did not have any effect, whereas overex-
pression of the core module consistently increased the inhibition
of growth in response to mTOR inhibition (Figure 3H).
The results of these experiments confirm that the core module
acts when mTOR is inhibited, whereas the 50 module does not
affect cell growth under these conditions. Together, these exper-
iments show that both the 50 module and the core module have
the capacity to regulate cell growth in leukemic T cells, but they
do so under different cellular conditions.
Distinct Structural Elements Are Required for GAS5
Module Functions
To test whether individual structural features present in the 50 or
core modules are required for function, we disrupted a set of
well-defined secondary structures in each GAS5 module. This6 Cell Reports 32, 107933, July 21, 2020strategy has been successfully applied in other studies to deter-
mine the precise location of functional RNA elements (Uroda
et al., 2019; Chillo´n and Pyle, 2016). The effects of mutations
were measured in leukemic T cells under normal growth condi-
tions for the 50 module (Figures 4A and 4B) and in the presence
of mTOR inhibitors for the core module (Figures 4C and 4D).
The 50 module contains six secondary structures of varying
length, ranging from 2 to 13 base pairs. We introducedmutations
to disrupt two well-defined structures with low SHAPE reactiv-
ities (50H2 and 50H3; Figure 5A). Expression of these constructs
in Jurkat or CEM-C7 cells showed that helix 50H2 is not required
for proper function of the 50 module (Figure 4B). No effect was
observed on cell viability or levels of apoptosis when compared
to the wild-type 50 module. Disruption of helix 50H3, however,
abolished effects on viability and apoptosis completely. Thus,
while the 50 module is mostly unstructured, it contains a small
hairpin structure (50H3) that is responsible for its negative effects
on cell survival.
The highly structured core module was tested in Jurkat cells
under conditions of mTOR inhibition. We chose four stable heli-
ces (cH4, cH6, cH11, and cH12) and introduced mutations to
disrupt these helices and probe their function in cells. Mutation
of helices cH11 and cH12 did not have an effect on the function
of the core module. Core module constructs containing muta-
tions in helices cH4 and cH6, however, were not able to reduce
Figure 5. Proteomics Analysis of GAS5 Interactions
(A) GO analysis of proteins significantly enriched in GAS5 samples over control. Shown are the GO terms (biological process) that have a Z score of at least 5 for at
least one sample. Z scores below 2 are not shown.
(B–D) Volcano plots of pairwise comparisons of proteins detected in pull-downs with the full-length GAS5 (B), the 50 module (C), and the core module (D) versus
control. Proteins enriched in the GAS5 pulldowns are shown in red, proteins enriched in the controls are shown in green, and proteins with p < 0.05 are shown in
blue. The CCR4-NOT complex proteins are highlighted as large yellow circles.
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is formed by long-range interactions between nucleotides 258–
272 and 463–476 (Figure 4C). It is located at the center of the
core module and bridges the three-way junction of helices
cH3, cH4, and cH12 with the multi-way junction connecting he-
lices cH4 to cH11. Disruption of this structure may have effects
on the integrity of the core module as a whole, which could
explain why it is required for function. Helix cH6 is part of a short,
seven-base-pair hairpin structure. Abolishing cH6 ablates the
core module’s effect on cell growth, suggesting that it is respon-
sible for mediating its activity directly.
While it is possible that mutations of individual secondary
structures may have broader effects on the overall structure of
the GAS5 modules, these experiments strongly support the
notion that the GAS5 structural modules we identified using
SHAPE-MaP contain defined secondary structure elements
that are required for their negative effects on basal cell survival
of leukemic T cells.
The GAS5 Protein Interactome
The presence of defined secondary structures required for the
function of GAS5 and its modules suggests that specific proteins
recognize these structures and mediate the downstream effects
of GAS5 on cell survival. To identify such proteins, we performed
pull-down experiments using biotinylated, in vitro transcribed
RNA and Jurkat cell lysates. Pull-downs were conducted with
full-length GAS5, the 50 module, the core module, or the com-
plete reverse complement of GAS5 as a negative control. Pro-
teins associating with these RNAs were then quantified using
mass spectrometry (Figure 5).
We found 273, 448, and 619 proteins significantly enriched
over controls in the full-length, 50, and core module samples,
respectively. Gene Ontology (GO) analyses of the proteins asso-
ciating with the GAS5 samples identified enriched RNA-related
processes (mRNA processing, splicing, ribonucleoprotein com-
plex assembly, translation elongation) for the full-length and core
modules. GO analysis of enriched proteins shows that the 50
module associates with proteins involved in the cell cycle, which
is in agreement with our cellular assays showing that the 50 mod-
ule, but not the core module, regulates cell survival throughchanges in the cell cycle (Figure 5A). Full-length GAS5, however,
did not enrich for these proteins. Individual pulldowns were not
performed with equimolar amounts of biotinylated RNA, but
rather with an equal mass (3 mg). As a result, the shorter 50 mod-
ule sample (167 nucleotides) contained approximately 4 times
more molecules compared to full-length GAS5. This may explain
a greater enrichment of cell cycle proteins for the 50 module.
A number of the most highly enriched proteins belong to
the CCR4-NOT (Carbon Catabolite Repression—Negative
On TATA-less) complex (CNOT1, CNOT2, CNOT3, CNOT6L,
CNOT7, CNOT9, CNOT10, and CNOT11; Figures 5B–5D). This
complex is enriched in all GAS5 samples, including the 50 and
core modules, suggesting that multiple parts of GAS5 are able
to associate with it. Interaction with this complex and modulation
of its activity would provide GAS5 with a broad platform to affect
cell survival at multiple steps in gene expression. The CCR4-NOT
complex is involved in almost all aspects of gene expression,
including chromatin modification and transcription as well as
mRNA processing, export, deadenylation, and translation
(Collart, 2016).
In summary, the proteomics analysis identified groups of pro-
teins that specifically interact with GAS5 and its structural mod-
ules. Differences between proteins associating with the different
modules allude to their different activities under varying cellular
conditions. These results may serve as a resource for further
investigation into the molecular mechanisms employed by
GAS5 to regulate cell survival.DISCUSSION
Their flexibility in size and structure and their unique ability to
form specific complexes with proteins, DNA, and other cellular
RNAs make lncRNAs ideal molecular scaffolds to bring together
different biomolecules in order to regulate and organize cellular
processes (Deveson et al., 2017). A modular structural architec-
ture is an important benefit, allowing lncRNAs to assemble
distinct, functionally independent effector complexes on
different parts of their structure and therefore diversify their func-
tional toolkit.Cell Reports 32, 107933, July 21, 2020 7
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gulated in numerous cancers. A short hairpin structure at its 30
terminus acts as a decoy for SRs and inhibits their signaling
(Hudson et al., 2014; Kino et al., 2010). Beyond that, not much
is known about how GAS5 reduces cell growth and viability
and which elements are required for these effects.
To further characterize GAS5 function, we determined its sec-
ondary structure in vitro and in cellulo using chemical probing
experiments (Figures 1 and 2). The results show that GAS5 con-
tains three structural modules with distinct sequence and struc-
ture: a 50 module with low secondary structure content, a highly
structured coremodule, and the previously predicted SR binding
short hairpin motif.
Highly modular structures have been observed for other
lncRNAs (Hawkes et al., 2016; Novikova et al., 2012; Somarow-
thu et al., 2015; Tsai et al., 2010), and the individual modules are
thought to be functionally important. The SR binding hairpin of
GAS5, for instance, has previously been shown to act indepen-
dently of the rest of the molecule via interaction with SRs (Hud-
son et al., 2014; Kino et al., 2010). Here, using functional assays
in leukemic T cells, we show that the 50 and the core modules
also function independently and do so in different cellular con-
texts. Under normal growth conditions in leukemic T cells, which
have little dependence on SR signaling, the 50 module is respon-
sible for many of the effects of GAS5 on cell viability, apoptosis,
and the cell cycle (Figure 3). The coremodule has no effect under
those conditions. When cells were treated with mTOR inhibitors,
however, we find that the core module is active, and the 50 mod-
ule has no effects (Figure 3). Under these conditions, the core
module recapitulates the previously observed function of GAS5
in mediating the inhibition of growth upon shutting down the
mTOR signaling pathway (Mourtada-Maarabouni et al., 2010).
Mutations within specific RNA secondary structure elements in
the 50 and core modules disrupt their effects in cells, showing
that distinct structural features are critical for each module’s
function. Thus, GAS5 uses its modular structural organization
to assemble distinct functional complexes on different parts of
its sequence, each modulating cell growth independent of the
other. This allows GAS5 to reliably respond to cellular stress in
different cell types and under different external conditions.
How did these structural modules of GAS5 arise? While there
is currently no evidence that GAS5 encodes a functional protein
product, it is possible that when the GAS5 gene first appeared in
evolution, its ORF initially produced a functional protein. GAS5
belongs to the family of 50 terminal oligopyrimidine (50 TOP)
genes (Smith and Steitz, 1998), which include all ribosomal pro-
teins as well as translation elongation factors. This suggests that
its initial function was related to translation. Over time, the tran-
script may have gained beneficial non-coding RNA functions in
its 30 untranslated region. Subsequently, with evolutionary pres-
sure low on the ORF itself, it lost its coding function, and GAS5
changed into a lncRNA gene. Here, we show that the 50 module,
which covers the putative ORF, functions independently at the
RNA level and regulates cell survival. This shows that the ORF
not only lost its coding function, but also gained novel, non-cod-
ing functions. Finally, the SR binding module at the GAS5 30 end
was added more recently in evolution via an Alu insertion in the
haplorrhine lineage (Hudson et al., 2014). As a result, human8 Cell Reports 32, 107933, July 21, 2020GAS5 now encodes a lncRNA with at least three structural mod-
ules, each with a separate, independent function.
The translation of 50 TOP genes is selectively inhibited under
conditions of nutrient deprivation. It is, thus, conceivable that
the non-coding functions of GAS5 evolved as part of the adap-
tive response to nutrient starvation, which involves the slowing
of cell growth as a means to enhance survival. Cells respond
to various kinds of stress with transcript-specific—such as for
the 50 TOP family—or general post-transcriptional mechanisms
that reprogram translation to favor survival (Ivanov et al., 2011).
By regulating GAS5 using NMD, a process that requires active
translation, cells ensure that any global negative effects on trans-
lation as a response to stress increase the levels of GAS5 so that
it can exert its antiproliferative effects. This establishes GAS5 as
a key effector in the cellular stress response.
Our understanding of the mechanisms employed by GAS5 to
regulate cell survival is still very limited. The GAS5 structural
modules identified here likely assemble into complexes with
other cellular components (proteins, DNA, and RNA) that
mediate GAS5’s effects. We used a proteomics approach to
identify proteins that specifically interact with GAS5 and its
structural modules. The results show strong interaction of
GAS5 with the CCR4-NOT machinery, suggesting that it may
modulate gene expression through this large multi-component
complex. However, further mechanistic explorations will be
necessary to substantiate these results and to gain further
insight into GAS5’s biological mechanism.STAR+METHODS
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OPEN ACCESSSTAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
DNase I New Endland Biolabs Cat#M0303S
Biotin-11-CTP Sigma Aldrich Cat#4739205001
Superscipt II reverse transcriptase Invitrogen Cat#M1302
MicrospinTM G-25 columns GE Healthcare Cat#27532501
Q5 High-Fidelity DNA polymerase New England Biolabs Cat#M0491S
AmpureXP beads Beckman Coulter Cat#A63880
Lysyl Endopeptidase Wako Chemicals Cat#12505061
Kapa Biosystems Hyperprep Plus DNA kit Roche Cat#07962380001
Streptavidin Magnetic Beads New England Biolabs Cat#S1420S
Trypsin Promega V5280
Rapamycin Sigma-Aldrich Cat#553210
Everolimus Sigma-Aldrich Cat#SML2282
Temsirolimus Sigma-Aldrich Cat#PZ0020
AZD8055 Selleckchem Cat#S1555
BEZ235 Selleckchem Cat#S1009
CellTiter 96 AQueous One Solution Cell
Proliferation Assay (MTS)
Promega Cat#G3582
Muse Cell Cycle Reagent Merck Millipore Cat#MCH100106
Acridine orange Thermo Fisher Scientific Cat#A1301
Random primers Invitrogen Cat#48190-011
RNaseOUT recombinant ribonuclease
inhibitor
Invitrogen Cat#10777019)
SensiFAST Probe Hi-ROX mix Bioline Cat#BIO-82020
Hs03671981_s1 Thermo Fisher Scientific Cat#4331182
Hs03464472_m1 Thermo Fisher Scientific Cat#4331182
Muse Annexin V & Dead Cell Kit Merck Millipore Cat#MCH100105
Muse Count & Viability Kit Merck Millipore Cat#MCH100102
Sperimidine Sigma-Aldrich Cat#S2626
Silencer Negative Control No. 1 siRNA Thermo Fisher Scientific Cat#AM4611
GAS5 siRNA#2 QIAGEN Cat#SI03652544
GAS5 siRNA#1 QIAGEN Cat#SI03652537
Critical Commercial Assays
RNeasy Mini Kit QIAGEN Cat#74104
PureLinkTM PCR purification kit Invitrogen Cat#K310001
Muse annexin V and dead cell assay kit Merck Millipore Cat#MCH100105
Cell Count and Viability Kit Merck Millipore Cat#MCH100102
Direct-zol RNA MiniPrep kit ZYMO RESEARCH Cat#R2050
Omniscript RT kit QIAGEN Cat#205111
Mycoalert Mycoplasma Detection Kit Lonza Cat#LT07-318
Deposited Data
Gas5 SHAPE data (in vitro data 1) This Paper https://doi.org/10.17632/98cwbscjvn.1
Gas5 SHAPE data (in vitro data 2) This Paper https://doi.org/10.17632/98cwbscjvn.1
Gas5 SHAPE data (in cellulo) This Paper https://doi.org/10.17632/98cwbscjvn.1
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Gas5 pull-down mass spectrometry
proteomics data
This Paper PXD018584
Experimental Models: Cell Lines
CCRF-CEM cell line (Subclone C7KM1) ATCC Cat#CCL-119
Jurkat, Clone E6-1 ATCC Cat#TIB-152
Oligonucleotides
Human GAS5 Exon 12: Forward primer
(CTTCTGGGCTCAAGTGATCCT)-
Applied Biosystems CTTCTGGGCTCAAGTGATCCT
Gas5_1-15_FW IDT TTTCGAGGTAGGAGTC
Human GAS5 Exon 12 Reverse primer Applied Biosystems TTGTGCCATGAGACTCCATCAG
pcDNA3_Gas5_FW IDT GCTAGCGTTTAAACTTAAGCTTGG
Gas5_400_RE IDT GATAACAGGTCTGCCTGCAT
Gas5_227_FW IDT TCCTGGTAACGTTTTTATCC
RT01 IDT GGATTGCAAAAATT
TATTAAAATTGGAGACA
Recombinant DNA
pcDNA3.1: Gas5 (1-167) 50H3mut This paper N/A
pcDNA3.1: Gas5 (163-545) cH4mut This paper N/A
pcDNA3.1: Gas5 (163-545) cH6mut This paper N/A
pcDNA3.1: Gas5 (163-545) cH11mut This paper N/A
pcDNA3.1: Gas5 (163-545) cH12mut This paper N/A
pcDNA3.1: Gas5 Hudson et al., 2014 N/A
pcDNA3.1: Gas5 (1-167) This paper N/A
pcDNA3.1: Gas5 (163-545) This paper N/A
pcDNA3.1: Gas5 (1-167) 50H2mut This paper N/A
Software and Algorithms
ShapeMapper 2 Siegfried et al., 2014 https://weekslab.com/software/
DeltaSHAPE Smola et al., 2015a https://weekslab.com/software/
RNAstructure Xu and Mathews, 2016 https://rna.urmc.rochester.edu/
RNAstructure.html
MaxQuant v1.6.01 MaxQuant https://www.maxquant.org
Thermo Foundation 2.0 Thermo Fisher https://www.thermofisher.com/us/en/
home/industrial/mass-spectrometry/
mass-spectrometry-software.html
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Eric Or-
tlund (eortlun@emory.edu).
Materials Availability
Plasmids generated in this study are available upon request.
Data and Code Availability
Raw sequencing data used for SHAPE analyses were deposited at Mendeley Data: https://data.mendeley.com/datasets/
98cwbscjvn/draft?a=c5ba08ab-66e3-4e4f-9f4a-25de8676cbe4
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repos-
itory with the dataset identifier PXD018584.e2 Cell Reports 32, 107933, July 21, 2020
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OPEN ACCESSEXPERIMENTAL MODEL AND SUBJECT DETAILS
Jurkat cell line (Clone E6-1) and apoptosis-sensitive cloned CEM-C7 CKM1 cell line (CCRF-CEM) were obtained from ATCC. Cells
were maintained in RPMI-1640 medium (Sigma) supplemented with 10% heat inactivated fetal calf serum (FCS; Hyclone), 2 mM
L-glutamine and 200 mg/ml gentamycin (Sigma), at 37C in a 5% CO2 humidified incubator. Both cell lines were mycoplasma-free
as tested with the Mycoalert Mycoplasma Detection Kit (Lonza, Slough, UK).
METHOD DETAILS
Preparation of RNA
Full-length GAS5 RNA was generated by in vitro transcription using recombinant T7 RNA polymerase and pcDNA3 containing GAS5
(NR_002578.2 bases 1–631). The in vitro transcription reaction was carried out in 50 mM Tris-HCl, pH 7.5, 25 mMMgCl2, 5 mM DTT
and 2 mM spermidine with 2 mM of each NTP. Recombinant T7 RNA polymerase (0.1 mg/ml) was added and the reaction was incu-
bated for 4 h at 37C. Sample was DNaseI treated, extracted with phenol/chloroform/IAA, and the RNA was PAGE-purified. Bio-
tinylated RNA for pull-down experiments was prepared under the same conditions with additional 0.5mM biotin-CTP present in
the transcription reaction.
Synthesis of 1-methyl-7-nitroisatoic anhydride
1M7 was synthesized as described previously (Turner et al., 2013).
Modification of in vitro transcribed GAS5 RNA with 1M7
SHAPE-MaP was carried out according to published protocols (Smola et al., 2015b). For each reaction 500ng RNA was prepared in
12 mL water, heated to 95 C for 2minutes, and placed on ice immediately. 6 mL of 3.3x folding buffer (333mMHEPES, pH8.0, 333mM
NaCl, 33mMMgCl2) was added and the sample was incubated at 37C for 20minutes to fold. 9 mL of sample was transferred to a tube
containing either 1 mL 100mM 1M7 in DMSO or plain DMSO as the no reagent control. After 75 s incubation at 37C the sample was
placed on ice and 40 mL water was added.
For the denaturing control reaction 250ng RNA was prepared in 3 ml water. 3 mL formamide and 1mL 10x denaturing control buffer
(500mMHEPES pH 8.0, 40 mM EDTA) was added and the sample was incubated at 95 C for 2 minutes to denature the RNA. The hot
sample was then transferred to a new tube containing 1 mL 100 mM 1M7, mixed well, and immediately incubated at 95 C for one
minute. Sample was then placed on ice and 40 mL water was added.
Finally, all samples were purified using the RNeasy Mini Kit (QIAGEN) according to the manufacturer’s instructions. The elution
volume was 150 mL.
Modification of cellular RNA with 1M7
Cells were plated in 6-well plates at 0.83 106 cells/well and grown for 4 days to reach density arrest under which endogenous GAS5
levels are increased(Smith and Steitz, 1998). Cells were washed with 1 mL of PBS, then 900 mL fresh growth medium and 100 mL
100mM 1M7 (or plain DMSO) were added, and the solution was immediately mixed by swirling the culture plate. Samples were incu-
bated for 5 minutes at 37 C, after which total RNA was extracted using TRIzolTM (Invitrogen).
Reverse transcription of 1M7 modified RNA
1 mL of primer RT01 at 2 mM was added to 10 mL of purified, modified (or control) RNA (or 3 mg of RNA modified in cellulo) and the
samples were incubated at 65 C for 5 minutes. After cooling on ice 8 mL 2.5x SHAPE MaP buffer (125 mM Tris (pH 8.0),
187.5 mM KCl, 15 mMMnCl2, 25 mM DTT and 1.25 mM dNTPs) was added and the samples were incubated at 42 C for 5 minutes.
Finally, 1 mL of Superscipt II reverse transcriptase (Invitrogen) was added and the samples were incubated at 42 C for 3 hours.
Reverse transcriptase was inactivated by incubation 70 C for 15minutes and samples were purified usingMicrospinTMG-25 columns
(GE Healthcare).
Amplification of cDNA for SHAPE-MaP
Two overlapping amplicons of GAS5 of 400 nt length were generated by PCR using Q5 High-Fidelity DNA polymerase (NEB).
Primers are listed in the Key Resources Table. 50mL PCR reactions were prepared and purified using a PureLinkTM PCR purification
kit (Invitrogen).
Library preparation and high-throughput sequencing
PCR amplicons were cleaned using the AmpureXP beads (Beckman Coulter). The DNA was quantified using a fluorometric based
method and 10 ng was used for library preparation using the Kapa Biosystems Hyperprep Plus DNA kit. The amplicons were
sequenced on an Illumina Miseq instrument in a paired-end 300 cycle format.
The raw sequencing data is available at: https://data.mendeley.com/datasets/98cwbscjvn/draft?a=c5ba08ab-66e3-4e4f-
9f4a-25de8676cbe4Cell Reports 32, 107933, July 21, 2020 e3
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SHAPE reactivity data was analyzed using the ShapeMapper 2 software, the arc plot was generated using the SuperFold software
(Siegfried et al., 2014), and SHAPE differences were calculated using theDeltaSHAPE software (Smola et al., 2015a) (all can found be
found at https://weekslab.com). GAS5 secondary structure was modeled using the RNAstructure software (https://rna.urmc.
rochester.edu/RNAstructure.html ) (Xu and Mathews, 2016) and in vitro SHAPE reactivity data.
Mutation rates of the in cellulo modified sample was lower than in vitro samples (0.06% median rate versus 0.09%, respectively;
Figures S2 and S3), most likely owing to limited diffusion of 1M7 into the cells. Mutation rates of denaturing controls for in cellulo
samples (generated by RNA extraction and exposure to 1M7 under denaturing conditions similar to in vitro samples) were too low
and not usable. Instead we used denaturing control data from in vitro SHAPE samples for in cellulo samples as well.
The resulting quality data generated from in cellulo samples was sufficient for analysis as evidenced by small relative standard er-
rors of SHAPE reactivities (Figure S2) and good agreement in the region of overlap between the two separate PCRs reactions em-
ployed to amplify the GAS5 cDNA: the two amplicons overlap between nucleotides 248 and 379 and SHAPE reactivities calculated
independently for each amplicon correlate well in that region (Spearman R = 0.70; Figure 2C).
Effects of GAS5 constructs on the basal survival of Jurkat and CEM-C7 leukemic T cells
Cells were transfected with GAS5 constructs, or empty pcDNA3 vector as control. After 24 h, cells were replated at a fixed density for
analysis after a further 48 h. Cellular GAS5 levels for Jurkat and CEM-C7 cells were determined by RT-qPCR at 24h post transfection
using two different Taqman assays, Hs03671981_s1 (exon 1) and Hs03464472_m1 (exon boundary 10-11, position 409).
Apoptosis was routinely determined by assessment of nuclearmorphology by fluorescencemicroscopy after staining with acridine
orange (25 mg/ml); cells containing condensed or fragmented chromatin were scored as apoptotic. Apoptosis level was also deter-
mined by flow cytometry using a Muse annexin V and dead cell assay kit, according to the manufacturer’s protocol (Merck Millipore,
Cat # MCH100105). Representative images of Annexin V stained Jurkat cells is shown in Figure S4.
Cell viability was determined using a commercial Cell Count and Viability Kit (Merck Millipore; Cat # MCH 100102) and aMuse flow
cytometer (Merck Millipore, Darmstadt, Germany) (Mohammed et al., 2016).
Cell cycle analysis was carried using nuclear propidium iodide (PI)-staining procedure and flow cytometry (Mohammed et al.,
2016). Transfected cells were harvested 24 hours post-transfection and re-plated in fresh medium at 2 3 105 cells/well in 6-well
plates. Following incubation for 48 hours, 1 million cells were washed in PBS before re-suspending the pellet in 200 mL PBS. Cells
were then fixed in 1 mL ice cold (70% ethanol / 30% PBS) and stored at –20C for at least 3 hours prior to cell cycle analysis. Fixed
cells were centrifuged for 5 minutes at 1500 rpm. The supernatant was discarded and the cell pellet was re-suspended in 200 mL of
Muse Cell Cycle Reagent (Merck Millipore # MCH100106). Cells were incubated for 30 minutes in the dark and data acquisition was
carried out using the Millipore Muse cell analyzer (Mohammed et al., 2016).
Effects of GAS5 constructs on cell growth in the presence of mTOR inhibitors
Jurkat cells were transfected with one of the constructs or empty vector. Cells were treated with the mTOR inhibitors 24 post trans-
fection. Cell growth was measured using MTS after 48 and 72 hours. Results are represented as the percentage inhibition of cell pro-
liferation relative to vehicle-treated cells.
For experiments with knock-down, Jurkat cells were transfected with specific GAS5 siRNAs (SI03652537 targeting exon 3 = siRNA
1; SI03652544 targeting exon 7 = siRNA2) or negative control siRNA ((-)siRNA) and cultured at 37C. After 48h, cells were transfected
with one of the constructs or empty vector and treated with Rapamycin (2.5 mM) 24h post transfection. Cell growth was measured
using MTS after 48 hours. Results are represented as the percentage inhibition of cell proliferation relative to vehicle-treated cells.
RNA-pulldown
The RNApulldown experiments were carried out described in Panda et al. (2016). For each individual pulldown sample approximately
2 million Jurkat cells were required. Each sample was done in quadruplicates from four different passages of cells. Cells were centri-
fuged at 500 g for 5 minutes, washed with PBS once and resuspended in lysis buffer (10 mM HEPES (pH7.5), 100 mM KoAc, 10 mM
MgoAc, 1% NP-40. 2.5 mM DTT, cOmplete Protease Inhibitor Cocktail (Roche)). Cells were snap frozen in liquid nitrogen, then
thawed, and incubated for 40 minutes on a nutating platform at 4 C. Samples were then spun down at 15,000 g for 15 minutes at
4 C. Protein concentrations were measured and each pulldown was done with 1mg of total protein. Biotinylated RNA was prepared
using recombinant T7 RNA Polymerase and buffers (see above). 3 mg of RNA (full-length GAS5, nucleotides 1-167, nucleotides 163-
545, or the complete GAS5 reverse complement sequence) was incubated with jurkat cell lysates (1 mg total protein) for three hours
on ice.
In the meantime, beads were prepared as follows. 50 mL of streptavidin magnetic beads (NEB) were used per pulldown reaction.
Beads were washed three timeswith lysis buffer (no protease inhibitors), incubated with 1mgBSA per 200 mL beads for one hour, and
washed four times with lysis buffer. Beads were then added to the RNA and jurkat cell lysates and incubated at 4 C overnight on a
nutating platform. Beads were then washed four times with lysis buffer (without NP-40) and finally resuspended in 50 mL lysis buffer
(without NP-40) for mass spectrometry analysis.e4 Cell Reports 32, 107933, July 21, 2020
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After removing the supernatant from the IP samples, the bead solutions were resuspended in 200ul of 50 mM NH4HCO3. The sam-
ples were reduced with 1mM dithiothreitol (DTT) for 30 minutes at room temperature. This was followed by alkylation with 5mM
iodoacetimide (IAA) for 30 minutes in the dark. The samples were then digested with 1:100 (w/w) lysyl endopeptidase (Wako) for
2 hours at room temperature. Trypsin (Promega) was added at 1:50 (w/w) and digestion was allowed to proceed overnight. The re-
sulting peptides solutions were desalted with a Sep-Pak C18 column (Waters) and dried under vacuum.
LC-MS/MS analysis
Dried peptides were reconstituted in 10 mL of loading buffer (0.1% formic acid, 0.03% TFA, 1% acetonitrile). The sample (2mL) was
loaded onto and eluted from a self-packed C18 fused silica column (25 cm x 75 mM internal diameter (ID); New Objective, Woburn,
MA) driven by a Easy nLC 1200 coupled to a Fusion mass spectrometer (ThermoFisher Scientific, San Jose, CA). Elution was per-
formed over a 140-minute gradient at a rate of 200 nl/min with buffer B ranging from 3% to 99% (buffer A: 0.1% formic acid in water,
buffer B: 0.1% formic in 80% acetonitrile). The mass spectrometer cycle was programmed to collect at the top speed for 3 s cycles
with higher-energy collision dissociation (HCD) fragmentation. The MS scans (350-1500 m/z range, 200,000 AGC, 50 ms maximum
ion time) were collected at a resolution of 120,000 at m/z 200 in profile mode while the HCDMS/MS spectra (1.2 m/z isolation width,
30% collision energy, 10,000 AGC target, 35 maximum ion time) were detected in the ion trap. Dynamic exclusion was set to exclude
previous sequenced precursor ions for 20 s within a 10 ppm window. Precursor ions with +1, and +7 or higher charge states were
excluded from sequencing.
Protein Identification and Quantification with MaxQuant
RAW data was analyzed using MaxQuant v1.6.01 with Thermo Foundation 2.0 for RAW file reading capability. The search engine
Andromeda was used to build and search a concatenated target-decoy UniProt Knowledgebase (UniProtKB) containing both
Swiss-Prot and TrEMBL human reference protein sequences (90,307target sequences downloaded April 21, 2015), plus 245
contaminant proteins included as a parameter for Andromeda search within MaxQuant (Cox et al., 2011). Methionine oxidation
(+15.9949 Da), and protein N-terminal acetylation (+42.0106 Da) were included as variable modifications (up to 5 allowed per pep-
tide); cysteine was assigned a fixed carbamidomethyl modification (+57.0215 Da). Only fully tryptic peptides were considered with up
to 2missed cleavages in the database search. A precursor mass tolerance of ± 20 ppm and a 0.6 Da product ion tolerance was used.
Other search settings included a maximum peptide mass of 4,600 Da, a minimum peptide length of 7 residues and match between
runs. The false discovery rate (FDR) for peptide spectral matches, proteins, and site decoy fraction were all set to 1 percent. Themass
spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019)
partner repository with the dataset identifier PXD018584.
QUANTIFICATION AND STATISTICAL ANALYSIS
Assays for determination of cell viability, apoptosis, survival, and cell cycle
Details about statistical analyses of these experiments can be found in the legend of Figures 3 and 4.
Mass Spectrometry Quantitative Data Processing and Statistics
MaxQuant grouped protein quantification based on the MaxLFQ normalization algorithm (Cox et al., 2014) was extracted from Max-
Quant output for 3,108 non-decoy proteins. Of these, 3,026 proteins were quantified in at least 3 out of 4 technical replicate LC-MS/
MS run RAW data for at least one of the 4 different RNA baits. This filtering is important because imputation according to an infor-
mative missingness assumption, or missing not at random (MNAR) values remain for these well-quantified proteins with consistent
non-missing quantification. LFQ normalized data for all but the outlier sample, determined later, had a Pearson correlation of at least
0.98 to unnormalized summed intensity data. Missing value imputation was performed in R according to the algorithm for LFQ inten-
sity imputation described by Tyanova et al., with each sample’s missing values imputed with a random distribution within 0.3 SD of
the population meanminus 1.8 SD of that sample’s population of nonmissing quantitations (Tyanova et al., 2016). Then outlier detec-
tion was performed using a 3SD cutoff for the z-scored connectivity measure calculated by the RWGCNA package fundamentalNet-
workConcepts function on an adjacency matrix calculated for the imputed LFQ data iteratively until no outliers could be found; one
outlier was removed (one replicate of the full-length GAS5 sample). One-way ANOVA with Tukey post hoc test for significance of
differences between pairs of grouped samples was performed in R using base functions and TukeyHSD. Then volcano plots using
Tukey p values were plotted in R using ggplot2 and plotly packages using an in-house script.Cell Reports 32, 107933, July 21, 2020 e5
